Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CYTX

Cytori Therapeutics

$0.26

0.008 (3.17%)

08:16
04/01/19
04/01
08:16
04/01/19
08:16
Earnings
Cytori Therapeutics reports Q4 adj. EPS (20c), two estimates (30c) »

Cytori ended the year…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Apr

Over a month ago
CYTX

Cytori Therapeutics

$0.32

-0.0102 (-3.09%)

16:35
02/01/19
02/01
16:35
02/01/19
16:35
Syndicate
Breaking Syndicate news story on Cytori Therapeutics »

Cytori Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$0.30

-0.0041 (-1.34%)

08:41
01/31/19
01/31
08:41
01/31/19
08:41
Hot Stocks
Cytori Therapeutics announces results from Cytori Cell Therapy trial published »

Cytori Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
BIOC

Biocept

$0.83

0.02 (2.47%)

, CYTX

Cytori Therapeutics

$0.27

-0.0051 (-1.83%)

08:30
12/24/18
12/24
08:30
12/24/18
08:30
Options
Twelve option delistings on December 24th »

Option delistings…

BIOC

Biocept

$0.83

0.02 (2.47%)

CYTX

Cytori Therapeutics

$0.27

-0.0051 (-1.83%)

ECYT

Endocyte

$24.00

(0.00%)

GEVO

Gevo

$2.07

-0.1 (-4.61%)

SSG

2nd Swing, Inc.

$22.50

0.9 (4.17%)

STBZ

State Bank Financial

$20.38

-0.6 (-2.86%)

SYBT

S.Y. Bancorp

$30.56

0.47 (1.56%)

XOXO

Taken private

$35.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$0.34

0.008 (2.45%)

07:55
12/03/18
12/03
07:55
12/03/18
07:55
Hot Stocks
Cytori Therapeutics receives Class III approval for Celution Cell Therapy System »

Cytori Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$0.34

-0.0064 (-1.87%)

07:21
11/15/18
11/15
07:21
11/15/18
07:21
Recommendations
Cytori Therapeutics analyst commentary at H.C. Wainwright »

Cytori Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$0.34

-0.0064 (-1.87%)

16:30
11/14/18
11/14
16:30
11/14/18
16:30
Earnings
Cytori Therapeutics reports Q3 EPS (27c), consensus (30c) »

Reports Q3 revenue $858K,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

CYTX

Cytori Therapeutics

$0.35

-0.005 (-1.41%)

09:30
10/30/18
10/30
09:30
10/30/18
09:30
Hot Stocks
Cytori Therapeutics announces receipt of Puregraft royalty milestone »

Cytori Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$0.41

-0.033 (-7.38%)

17:31
09/21/18
09/21
17:31
09/21/18
17:31
Syndicate
Breaking Syndicate news story on Cytori Therapeutics »

Cytori Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$0.49

-0.0108 (-2.18%)

09:32
09/17/18
09/17
09:32
09/17/18
09:32
Hot Stocks
Cytori Therapeutics receives FDA orphan drug designation for ATI-1123 »

Cytori Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.